Investigating the causal impact of gut microbiota on glioblastoma: a bidirectional Mendelian randomization study

被引:0
作者
Chuan Zeng
Chaolong Zhang
Chunming He
Haimin Song
机构
[1] First Affiliated Hospital of Gannan Medical University,Department of Neurosurgery
[2] The First Clinical Medical College of Gannan Medical University,undefined
来源
BMC Genomics | / 24卷
关键词
Glioblastoma; Gut microbiota; Mendelian randomization; Causality; Gut-brain axis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 176 条
  • [1] McKinnon C(2021)Glioblastoma: clinical presentation, diagnosis, and management BMJ 374 n1560-996
  • [2] Nandhabalan M(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987-312
  • [3] Murray SA(2020)Management of glioblastoma: State of the art and future directions CA Cancer J Clin 70 299-1010
  • [4] Plaha P(2020)Effect of Nivolumab vs bevacizumab in patients with recurrent glioblastoma: the checkMate 143 phase 3 randomized clinical trial JAMA Oncol 6 1003-521
  • [5] Stupp R(2021)Immunotherapy for glioblastoma: current progress and challenges Front Immunol 12 502-388
  • [6] Mason WP(2022)Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells Cancer Discov. 12 375-495
  • [7] van den Bent MJ(2018)The meningeal lymphatic system: a new player in neurophysiology Neuron 100 482-442
  • [8] Tan AC(2018)Multidimensional communication in the microenvirons of glioblastoma Nat Rev Neurol 14 422-228
  • [9] Ashley DM(2018)Current state of immunotherapy for glioblastoma Nat Rev Clin Oncol 15 199-580
  • [10] López GY(2017)Microbes and cancer Annu Rev Immunol 35 570-1094